Literature DB >> 21115927

Hormone receptor rate, MIB-1 score and serum tumour markers CEA and CA 15-3 relationship in elderly women with pT1-2 breast cancer.

Franco Lumachi1, Lorenzo Norberto, Filippo Marino, Stefano M M Basso, Bernardo Marzano, Giordano B Chiara.   

Abstract

The aim of this study was to analyse whether preoperative serum levels of CEA and CA 15-3 correlate with oestrogen (ER) and progesterone (PR) receptor rate and MIB-1 score in elderly (>65 years) women with breast cancer (BC). Data from a series of 349 women (median age 61 years, range 26-89) with pT1-2 BC who underwent curative surgery were reviewed. Patients were divided into two groups: Group A, 237 (60.2%) women <65 years, and Group B, 157 (39.8%) women >64 years. Size of the tumour, ER, PR, CEA and CA 15-3 preoperative serum levels were higher in older patients, while the MIB-1 rate was lower. In both groups, a significant (p<0.05) inverse correlation between ER and MIB-1 was found, while there was a relationship between MIB-1 and both PG and CA 15-3 only in younger patients. These data suggest that only MIB-1 index should be considered an effective parameter for assessing tumour proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115927

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.

Authors:  Xi Wu; Hiromi Tanaka
Journal:  Oncotarget       Date:  2015-10-06

2.  Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.

Authors:  Ziqiang Lin; James Neiswender; Bin Fang; Xuelei Ma; Jing Zhang; Xiuying Hu
Journal:  Oncotarget       Date:  2017-04-18

Review 3.  Biology of primary breast cancer in older women beyond routine biomarkers.

Authors:  R M Parks; L H Alfarsi; A R Green; K L Cheung
Journal:  Breast Cancer       Date:  2021-06-24       Impact factor: 4.239

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.